# OnCo record nct06190899 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06190899/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06190899", "NCT06190899" ;
  schema:name "Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer"@en ;
  schema:description "A phase 1/2 trial of Gedatolisib, Darolutamide in prostate cancer, run by Celcuity Inc, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06190899/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06190899> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2024-01-01" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/gedatolisib/>, <https://onco.cc/drugs/darolutamide/> ;
  onco:companies <https://onco.cc/companies/celcuity/> .